Virginia Retirement Systems’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Virginia Retirement Systems’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$439K	Sell	3,700 -2,900	-44%	-$362K	﹤0.01%	885
2021 Q4	$910	Buy	6,600 +1,900	+40%	+$242K	0.01%	688
2021 Q3	$653K	Buy	4,700 +700	+18%	+$87.4K	0.01%	739
2021 Q2	$388K	Buy	4,000 +600	+18%	+$48.7K	﹤0.01%	884
2021 Q1	$232K	Sell	3,400 -900	-21%	-$72.8K	﹤0.01%	1052
2020 Q4	$369K	Buy	4,300 +700	+19%	+$59.3K	﹤0.01%	935
2020 Q3	$234K	Sell	3,600 -700	-16%	-$45.9K	﹤0.01%	1003
2020 Q2	$314K	Buy	+4,300	New	+$229K	﹤0.01%	937
2019 Q2	–	Sell	-15,200	Closed	-$782K	–	1225
2019 Q1	$782K	Buy	+15,200	New	+$657K	0.01%	753

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Virginia Retirement Systems's BHVN Position: Q1 2022 in Review

Virginia Retirement Systems reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 44% in Q1 2022, selling an estimated $362K and leaving 3,700 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Virginia Retirement Systems first reported a position in BHVN in Q1 2019 and has held it in 9 quarters since. The position peaked at $782K in Q1 2019. 307 funds tracked by Wall St. Rank hold BHVN as of Q1 2022.

Virginia Retirement Systems held 3,700 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $439K as of Q1 2022.
Virginia Retirement Systems sold 2,900 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2022, an estimated $362K.
Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #885 holding.
Virginia Retirement Systems first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and has held it in 9 quarters since.
Virginia Retirement Systems's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $782K in Q1 2019.
307 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.